Skip to Content
Merck
All Photos(1)

Documents

915963

Sigma-Aldrich

TissueFab® bioink Conductive

Vis/405 nm

Synonym(s):

3D Bioprinting, Bioink, GelMA, TissueFab

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352201
NACRES:
NA.23

description

0.2 μm sterile filtered, suitable for 3D bioprinting applications

Quality Level

form

gel form (viscous)

impurities

≤5 CFU/g Bioburden (Fungal)
≤5 CFU/g Bioburden (Total Aerobic)

color

black

pH

6.5-7.5

application(s)

3D bioprinting

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Application

TissueFab®- GelMA-Conductive-Vis bioink is an electrically conductive bioink for 3D bioprinting applications. It is intended to generate ideal cell environments for neural, muscle and cardiac cells, which enable them to transfer electrical signals, enhancing cell communication and capacity for network formation. It is based on gelatin methacryloyl (GelMA) hydrogel system. Carbon nanotubes (CNTs) are incorporated to introduce conductivity, meanwhile enhance the mechanical properties of GelMA hydrogels.

Legal Information

TISSUEFAB is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Su Ryon Shin et al.
ACS nano, 7(3), 2369-2380 (2013-02-01)
We engineered functional cardiac patches by seeding neonatal rat cardiomyocytes onto carbon nanotube (CNT)-incorporated photo-cross-linkable gelatin methacrylate (GelMA) hydrogels. The resulting cardiac constructs showed excellent mechanical integrity and advanced electrophysiological functions. Specifically, myocardial tissues cultured on 50 μm thick CNT-GelMA

Articles

Bioinks enable 3D bioprinting of tissue constructs for drug screening and transplantation; select suitable bioinks for specific tissue engineering.

Learn how 3D bioprinting is revolutionizing drug discovery with highly-controllable cell co-culture, printable biomaterials, and its potential to simulate tissues and organs. This review paper also compares 3D bioprinting to other advanced biomimetic techniques such as organoids and organ chips.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service